IGF-1LR3
Long-Arg3 IGF-1, a modified analogue with reduced binding-protein affinity and a longer half-life.
How it works
Substitutions extend systemic availability of free IGF-1, activating IGF-1R signalling on muscle, tendon, and nerve.
Reported benefits
- Sustained anabolic IGF-1 signal
- Used in cell-culture research
- Investigated for tendon repair
Dosage & administration
Research range: 20-50 mcg subcutaneously per training day.
Dosing information is summarised from published clinical and pre-clinical literature for research purposes only and does not constitute medical advice.
Safety & warnings
- Hypoglycemia possible
- Avoid with active malignancy
- Long-term human safety unknown
For research use. Consult a licensed clinician before any human application. Not for use in pregnancy, lactation, or active malignancy without specialist supervision.
Available presentations
0.1 mg
IG01
Box of 10 · $135
Single vial · $270
1 mg
IG1
Box of 10 · $660
Single vial · $1,320
Related guides
BPC 157
A pentadecapeptide derived from human gastric juice with broad regenerative effects in pre-clinical models.
TB500 (Thymosin B4 Acetate)
A synthetic fragment of thymosin β-4 that promotes cell migration, angiogenesis, and tissue repair.
BPC + TB Blend
Combined BPC 157 and TB500 blend used in recovery protocols to overlap angiogenic and cytoskeletal effects.